Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo

American Journal of Physiology - Cell Physiology

Volumn 295, Issue 2, 2008, Pages

  Mizuno, Yusuke ^a   Isotani, Eiji ^a,b   Huang, Jian ^a   Ding, Hailei ^a   Stull, James T ^a   Kamm, Kristine E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bladder; Calmodulin; Myosin light chain phosphatase; Myosin regulatory light chain; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM ION; CALPHOSTIN C; CARBACHOL; CPI 17; ENZYME INHIBITOR; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN PHOSPHATASE TARGETING SUBUNIT 1; PHOSPHATASE; POTASSIUM CHLORIDE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; AMIDE; CALCIUM; CALMODULIN; MUSCLE PROTEIN; MYOSIN LIGHT CHAIN; MYPT1 PROTEIN, MOUSE; NAPHTHALENE DERIVATIVE; PHOSPHOPROTEIN; PPP1R14A PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BLADDER MUSCLE; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MOUSE; MUSCLE CONTRACTION; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE; ANIMAL; BLADDER; CALCIUM SIGNALING; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MUSCLE ISOMETRIC CONTRACTION; PHOSPHORYLATION; PHYSIOLOGY; TRANSGENIC MOUSE;

AMIDES; ANIMALS; CALCIUM; CALCIUM SIGNALING; CALMODULIN; CARBACHOL; ISOMETRIC CONTRACTION; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NAPHTHALENES; PHOSPHOPROTEINS; PHOSPHORYLATION; POTASSIUM CHLORIDE; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PYRIDINES; RHO-ASSOCIATED KINASES; URINARY BLADDER;

EID: 55949091220     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.90645.2007     Document Type: Article

References (43)

1. Barandier C, Ming XF, Rusconi S, Yang Z. PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem Biophys Res Commun 304: 714-719, 2003.
2. Bradley AB, Morgan KG. Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol 385: 437-448, 1987.
3. Brozovich FV. Myosin light chain phosphatase: it gets around. Circ Res 90: 500-502, 2002.
4. Colburn JC, Michnoff CH, Hsu LC, Slaughter CA, Kamm KE, Stull JT. Sites phosphorylated in myosin light chain in contacting smooth muscle. J Biol Chem 263: 19166-19173, 1988.
5. Deng JT, Sutherland C, Brautigan DL, Eto M, Walsh MP. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367: 517-524, 2002.
6. 2+ sensitization of contraction in arterial smooth muscle. Circ Res 100: 121-129, 2007.
7. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem (Tokyo) 118: 1104-1107, 1995.
8. 2+/calmodulin binding and activation of myosin light chain kinase in cells. FEBS Lett 557: 121-124, 2004.
9. Gomez-Pinilla PJ, Gomez MF, Swärd K, Hedlund P, Hellstrand P, Camello PJ, Andersson KE, Pozo MJ. Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res 44: 416-425, 2008.
10. Hamaguchi T, Ito M, Feng J, Seko T, Koyama M, Machida H, Takase K, Amano M, Kaibuchi K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by protein kinase N. Biochem Biophys Res Commun 274: 825-830, 2000.
11. 2+/force relationship during the contraction-relaxation cycle in the guinea pig ileum. Pflügers Arch 416: 28-35, 1990.
12. 2+ sensitization in rat ileal longitudinal smooth muscle. Am J Physiol Gastrointest Liver Physiol 293: G699-G710, 2007.
13. Isotani E, Zhi G, Lau KS, Huang J, Mizuno Y, Persechini A, Geguchadze R, Kamm KE, Stull JT. Real-time evaluation of myosin light chain kinase activation in smooth muscle tissues from a transgenic calmodulin-biosensor mouse. Proc Natl Acad Sci USA 101: 6279-6284, 2004.
14. 2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae. J Physiol 546: 823-836, 2003.
15. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276: 4527-4530, 2001.
16. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25: 593-620, 1985.
17. Kitazawa T, Eto M, Woodsome TP, Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility. J Biol Chem 275: 9897-9900, 2000.
18. 2+ sensitization in rabbit smooth muscle. J Physiol 546: 879-889, 2003.
19. 2+ sensitization in Triton X-100-demembranated rabbit arterial smooth muscle. J Physiol 520: 139-152, 1999.
20. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475: 197-200, 2000.
21. Lau KS, Grange RW, Chang WJ, Kamm KE, Sarelius I, Stull JT. Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide. FEBS Lett 431: 71-74, 1998.
22. MacDonald JA, Eto M, Borman MA, Brautigan DL, Haystead TAJ. Dual Ser and Thr phosphorylation of CPI-17, an inhibotor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett 493: 91-94, 2001.
23. Miller-Hance WC, Miller JR, Wells JN, Stull JT, Kamm KE. Biochemical events associated with activation of smooth muscle contraction. J Biol Chem 263: 13979-13982, 1988.
24. 2+ desensitization of myosin light chain phosphorylation and contraction in phasic smooth muscle. Mol Cell Biochem 190:91-98, 1999.
25. Muranyi A, Derkach D, Erdodi F, Kiss A, Ito M, Hartshorne DJ. Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett 579: 6611-6615, 2005.
26. Murthy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 68: 345-374, 2006.
27. Niiro N, Koga Y, Ikebe M. Agonist-induced changes in the phosphorylation of the myosin-binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 369: 117-128, 2003.
28. Nozu F, Tsunoda Y, Ibitayo AI, Bitar KN, Owyang C. Involvement of RhoA and its interaction with protein kinase C and Src in CCK-stimulated pancreatic acini. Am J Physiol Gastrointest Liver Physiol 276: G915-G923, 1999.
29. Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 278: 48794-48804, 2003.
30. Pang H, Bitar KN. Direct association of RhoA with specific domains of PKC-α. Am J Physiol Cell Physiol 289: C982-C993, 2005.
31. 2+-dependent and independent mechanisms. J Physiol 560: 839-855, 2004.
32. Shin HM, Je HD, Gallant C, Tao TC, Hartshorne DJ, Ito M, Morgan KG. Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 90: 546-553, 2002.
33. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358, 2003.
34. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
35. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000.
36. Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, Somlyo AP. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. FASEB J 17: 223-234, 2003.
37. Stull JT, Lin PJ, Krueger JK, Trewhella J, Zhi G. Myosin light chain kinase: functional domains and structural motifs. Acta Physiol Scand 164: 471-482, 1998.
38. 2+ sensitization of myosin phosphorylation and force in guinea-pig ileum. J Physiol 522: 33-49, 2000.
39. Swärd K, Mita M, Wilson DP, Deng JT, Susnjar M, Walsh MP. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep 5: 66-72, 2003.
40. Takizawa N, Koga Y, Ikebe M. Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. Biochem Biophys Res Commun 297: 773-778, 2002.
41. Wang Y, Yoshioka K, Azam MA, Takuwa N, Sakurada S, Kayaba Y, Sugimoto N, Inoki I, Kimura T, Kuwaki T, Takuwa Y. Class II phosphoinositide 3-kinase α-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle. Biochem J 394: 581-592, 2006.
42. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem J 389: 763-774, 2005.
43. 2+ sensitivity of protein kinase C-induced contractin in rabbit smooth muscle. J Physiol 535: 553-564, 2001.